Structural biology of carbohydrate xenoantigens

Expert Opinion on Biological Therapy

Volumn 9, Issue 8, 2009, Pages 1017-1029

  Yuriev, Elizabeth ^b   Agostino, Mark ^b   Farrugia, William ^a   Christiansen, Dale ^c   Sandrin, Mauro S ^c   Ramsland, Paul A ^a,c,d  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Antibody structure function relationships; Carbohydrate antigens; Lectin recognition; Xenotransplantation

Indexed keywords

CARBOHYDRATE ANTIGEN; EPITOPE; GALACTOSE; GALACTOSYLGALACTOSE; HETEROANTIGEN; LECTIN; LIPID; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; CONFORMATION; DNA MODIFICATION; HUMAN; HYPERACUTE GRAFT REJECTION; NONHUMAN; REVIEW; SWINE; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, HETEROPHILE; BINDING SITES; CARBOHYDRATES; EPITOPES; GALACTOSYLTRANSFERASES; HUMANS; LECTINS; LIPIDS; MOLECULAR CONFORMATION; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION, HETEROLOGOUS;

SUIDAE;

EID: 67650685623     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590903066703     Document Type: Review

References (73)

1. Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Transfus Apher Sci 2006;35:45-58 (Pubitemid 44354321)
2. Holgersson J, Gustafsson A, Breimer ME. Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies. Immunol Cell Biol 2005;83:694-708 (Pubitemid 43083102)
3. Ramsland P. Blood brothers: carbohydrates in xenotransplantation and cancer immunotherapy. Immunol Cell Biol 2005;83:315-317 (Pubitemid 41044608)
4. Roux FA, Sai P, Deschamps JY. Xenotransfusions, past and present. Xenotransplantation 2007;14:208-216
5. Cooper DK, Ezzelarab M, Hara H, Ayares D. Recent advances in pig-to-human organ and cell transplantation. Expert Opin Biol Ther 2008;8:1-4 (Pubitemid 351233718)
6. Cooper DK, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993;1:198-205 (Pubitemid 2020157)
7. Sandrin MS, McKenzie IF. Galα(1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 1994;141:169-190
8. Nydegger U, Mohacsi P, Koestner S, et al. ABO histo-blood group system-incompatible allografting. Int Immunopharmacol 2005;5:147-153 (Pubitemid 39626699)
9. Baldwin WM 3rd, Paul LC, Claas FH, Daha MR. Destructive and protective effects of antibody on transplants in humans: practical and theoretical considerations. Prog Clin Biol Res 1986;224:41-67
10. Porter KA. The effects of antibodies on human renal allografts. Transplant Proc 1976;8:189-197
11. Baumann BC, Stussi G, Huggel K, et al. Reactivity of human natural antibodies to endothelial cells from Galα(1,3)Gal-deficient pigs. Transplantation 2007;83:193-201
12. Galili U, Macher BA, Buehler J, Shohet SB. Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1-3)-linked galactose residues. J Exp Med 1985;162:573-582
13. Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992;24:559-562
14. Sandrin MS, Vaughan HA, Dabkowski PL, Mckenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal(α 1-3)Gal epitopes. Proc Natl Acad Sci USA 1993;90:11391-11395 (Pubitemid 23354435)
15. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002;20:251-255 (Pubitemid 34205417)
16. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002;295:1089-1092 (Pubitemid 34132242)
17. Phelps CJ, Koike C, Vaught TD, et al. Production of α1,3- galactosyltransferase-deficient pigs. Science 2003;299:411-414
18. Nottle MB, Beebe LF, Harrison SJ, et al. Production of homozygous α-1,3-galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation 2007;14:339-344 (Pubitemid 47174364)
19. Milland J, Christiansen D, Lazarus BD, et al. The molecular basis for Galα(1,3)Gal expression in animals with a deletion of the α1,3galactosyltransferase gene. J Immunol 2006;176:2448-54 • The iGb3S enzyme was cloned from mouse thymus and iGb3S mRNA expression was shown in certain mouse and pig tissues, which suggests that Galα(1,3)Gal epitopes are synthesized by iGb3S in GGTA1 knockout mice and possibly by pig iGb3S.
20. Sharma A, Naziruddin B, Cui C, et al. Pig cells that lack the gene for α1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003;75:430-6 • This study shows that reduced levels of Galα(1,3)Gal may remain in certain pig cells lacking α1,3GT. (Pubitemid 36241133)
21. Milland J, Christiansen D, Sandrin MS. α1,3-galactosyltransferase knockout pigs are available for xenotransplantation: are glycosyltransferases still relevant? Immunol Cell Biol 2005;83:687-693
22. Larsen RD, Rajan VP, Ruff MM, et al. Isolation of a cDNA encoding a murine UDPgalactose:β-D-galactosyl- 1, 4-N-acetyl-D-glucosaminide α-1, 3-galactosyltransferase: expression cloning by gene transfer. Proc Natl Acad Sci USA 1989;86:8227-8231 (Pubitemid 19286032)
23. Lazarus BD, Milland J, Ramsland PA, et al. Histidine 271 has a functional role in pig α-1,3galactosyltransferase enzyme activity. Glycobiology 2002;12:793-802 (Pubitemid 36150166)
24. Galili U, Shohet SB, Kobrin E, et al. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988;263:17755-17762
25. Larsen RD, Rivera-Marrero CA, Ernst LK, et al. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase cDNA. J Biol Chem 1990;265:7055-7061
26. Keusch JJ, Manzella SM, Nyame KA, et al. Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids. J Biol Chem 2000;275:25308-25314 (Pubitemid 30687027)
27. Taylor SG, Mckenzie IF, Sandrin MS. Characterization of the rat α(1,3) galactosyltransferase: evidence for two independent genes encoding glycosyltransferases that synthesize Galα(1,3)Gal by two separate glycosylation pathways. Glycobiology 2003;13:327-337
28. Kiernan K, Harnden I, Gunthart M, et al. The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant 2008;8:1829-1839
29. Diswall M, Angstrom J, Schuurman HJ, et al. Studies on glycolipid antigens in small intestine and pancreas from α1,3-galactosyltransferase knockout miniature swine. Transplantation 2007;84:1348-1356 (Pubitemid 351339324)
30. Puga Yung G, Schneider MK, Seebach JD. Immune responses to α1,3 galactosyltransferase knockout pigs. Curr Opin Organ Transplant 2009;14:154-160
31. Christiansen D, Milland J, Mouhtouris E, et al. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol 2008;6:e172. Published online 15 July 2008, doi:10.1371/journal.pbio.0060172 •• This work has established that the gene encoding iGb3S is non-functional in humans. Futhermore, the findings reveal that iGb3 or poly-α-Gal glycosphingolipids produced by iGb3S are possible important xenoantigens, which are recognized by antibodies and natural killer T cells.
32. Speak AO, Cerundolo V, Platt FM. CD1d presentation of glycolipids. Immunol Cell Biol 2008;86:588-597
33. Grahn E, Askarieh G, Holmner A, et al. Crystal structure of the Marasmius oreades mushroom lectin in complex with a xenotransplantation epitope. J Mol Biol 2007;369:710-21 • A crystal structure of a mushroom lectin (MOA) with high affinity and specificity for Galα(1,3)Galβ(1,4)GlcNAc was determined in complex with the trisaccharide. The structural basis for recognition of the major xenoantigen is revealed and MOA is suggested to be useful in combination with I-B4 and antibodies in screening tissues for xenoantigens. (Pubitemid 46709914)
34. Greco A, Ho JG, Lin SJ, et al. Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 2006;13:460-461 (Pubitemid 43881588)
35. Walser PJ, Haebel PW, Kunzler M, et al. Structure and functional analysis of the fungal galectin CGL2. Structure 2004;12:689-702 (Pubitemid 38447171)
36. Teneberg S, Lonnroth I, Torres Lopez JF, et al. Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology 1996;6:599-609 (Pubitemid 26386373)
37. Kirkeby S, Winter HC, Goldstein IJ. Comparison of the binding properties of the mushroom Marasmius oreades lectin and Griffonia simplicifolia I-B4 isolectin to αgalactosyl carbohydrate antigens in the surface phase. Xenotransplantation 2004;11:254-261 (Pubitemid 38623062)
38. Blanchard B, Nurisso A, Hollville E, et al. Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I. J Mol Biol 2008;383:837-53 • The crystal structure of the complex between Galα(1,3)Galβ(1,4)Glc and a lectin reveals a possible mechanism for binding to iGb3 or poly-α-Gal glycosphingolipids produced by iGb3S.
39. Natchiar SK, Srinivas O, Mitra N, et al. Structural studies on peanut lectin complexed with disaccharides involving different linkages: further insights into the structure and interactions of the lectin. Acta Crystallogr D Biol Crystallogr 2006;62:1413-1421 (Pubitemid 44630222)
40. Tempel W, Tschampel S, Woods RJ. The xenograft antigen bound to Griffonia simplicifolia lectin 1-B4. X-ray crystal structure of the complex and molecular dynamics characterization of the binding site. J Biol Chem 2002;277:6615-21 •• The first crystal structure of a protein (I-B4 lectin) in complex with Galα(1,3) Gal, which provided the first glimpse of a potential end-on insertion mechanism for natural antibody recognition of the major carbohydrate xenoantigen. (Pubitemid 34968462)
41. Lescar J, Loris R, Mitchell E, et al. Isolectins I-A and I-B of Griffonia (Bandeiraea) simplicifolia. Crystal structure of metal-free GS I-B4 and molecular basis for metal binding and monosaccharide specificity. J Biol Chem 2002;277:6608-6614 (Pubitemid 34968461)
42. Milland J, Yuriev E, Xing PX, et al. Carbohydrate residues downstream of the terminal Galα(1,3)Gal epitope modulate the specificity of xenoreactive antibodies. Immunol Cell Biol 2007;85:623-32 •• A demonstration that selective antibody binding of iGb3S produced glycosphingolipids was due to antibody discrimination between GlcNAc or Glc at the third position of Galα(1,3) Gal-containing carbohydrate chains. Structural models of antibodies and carbohydrate docking studies were used to predict the mechanism of binding and selective recognition of the two major Galα(1,3)Gal xenoantigens.
43. Kirkeby S, Moe D. Lectin interactions with α-galactosylated xenoantigens. Xenotransplantation 2002;9:260-7 44. Imberty A, Mikros E, Koca J, et al. Computer simulation of histo-blood group oligosaccharides: energy maps of all constituting disaccharides and potential energy surfaces of 14 ABH and Lewis carbohydrate antigens. Glycoconj J 1995;12:331-349 (Pubitemid 36358950)
44. Strotz CA, Cerezo AS. Use of a general purpose force-field (MM2) for the conformational analysis of the disaccharide α-D-galactopyranosyl-(1-3)- β-D-galactopyranose. J Carb Chem 1994;13:235-247
45. Corzana F, Bettler E, Herve DU, et al. Solution structure of two xenoantigens: αGal-LacNAc and αGal-Lewis X. Glycobiology 2002;12:241-250 (Pubitemid 34760069)
46. Li J, Ksebati MB, Zhang W, et al. Conformational analysis of an α-galactosyl trisaccharide epitope involved in hyperacute rejection upon xenotransplantation. Carbohydr Res 1999;315:76-88 (Pubitemid 29241835)
47. Otter A, Lemieux RU, Ball RG, et al. Crystal state and solution conformation of the B blood group trisaccharide α-L-Fucp-(1→2)- [α-D-Galp]-(1→3)]-β-D-Galp-OCH3. Eur J Biochem 1999;259:295-303 (Pubitemid 29030849)
48. Lamba D, Segre AL, Glover S, et al. Molecular structure of 3-O- (3,6-anhydro-α-D-galactopyranosyl)- β-D-galactopyranose (neocarrabiose) in the solid state and in solution: an investigation by X-ray crystallography, n.m.r. spectroscopy, and molecular mechanics calculations. Carbohydr Res 1990;208:215-230
49. Yuriev E, Farrugia W, Scott AM, Ramsland PA. Three-dimensional structures of carbohydrate determinants of Lewis system antigens: implications for effective antibody targeting of cancer. Immunol Cell Biol 2005;83:709-717 (Pubitemid 43083103)
50. Ramsland PA, Farrugia W, Yuriev E, et al. Evidence for structurally conserved recognition of the major carbohydrate xenoantigen by natural antibodies. Cell Mol Biol (Noisy-le-grand) 2003;49:307-317
51. Lee M, Lloyd P, Zhang X, et al. Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification scheme. J Org Chem 2006;71:5082-5092
52. Ramsland PA, Farrugia W, Bradford TM, et al. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens. J Mol Biol 2004;340:809-818 (Pubitemid 38829640)
53. Calarese DA, Scanlan CN, Zwick MB, et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 2003;300:2065-71
54. Cygler M, Rose DR, Bundle DR. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 1991;253:442-445 (Pubitemid 21917173)
55. Vulliez-Le Normand B, Saul FA, Phalipon A, et al. Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody. Proc Natl Acad Sci USA 2008;105:9976-9981
56. McKenzie IF, Li YQ, Patton K, et al. A murine model of antibody-mediated hyperacute rejection by galactose-α(1,3) galactose antibodies in Gal o/o mice. Transplantation 1998;66:754-763
57. Nozawa S, Xing PX, Wu GD, et al. Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-α(1,3)gal target antigens in the gal knockout mouse. Transplantation 2001;72:147-155
58. Yuriev E, Sandrin MS, Ramsland PA. Antibody-ligand docking: insights into peptide-carbohydrate mimicry. Mol Simulation 2008;34:461-468
59. Ekser B, Rigotti P, Gridelli B, Cooper DK. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol 2009;21:87-92
60. Cowan PJ, d'Apice AJ. Complement activation and coagulation in xenotransplantation. Immunol Cell Biol 2009;87:203-208
61. Sandrin MS. Gal knockout pigs: any more carbohydrates? Transplantation 2007;84:8-9
62. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 2003;100:12045-50 •• A demonstration that small amounts of Neu5Gc (a non-human sialic acid) could be incorporated into human cells, but cannot be synthesized unlike all other mammals including our closest relative, the chimpanzee. Comparison of human and chimpanzee sera revealed that most humans have natural antibodies to Neu5Gc. Furthermore, humans were shown to have significantly higher levels of Galα(1,3)Gal antibodies than chimpanzees. (Pubitemid 37271512)
63. Cairns T, Lee J, Goldberg LC, et al. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation. Transplant Proc 1996;28:795-796
64. Bouhours D, Liaigre J, Naulet J, et al. A novel pentaglycosylceramide in ostrich liver, IV4-β-Gal-nLc4Cer, with terminal Gal(β1-4)Gal, a xenoepitope recognized by human natural antibodies. Glycobiology 2000;10:857-864 (Pubitemid 30673920)
65. Lucq J, Tixier D, Guinault AM, et al. The target antigens of naturally occurring human anti-β-galactose IgG are cryptic on porcine aortic endothelial cells. Xenotransplantation 2000;7:3-13 (Pubitemid 30253152)
66. Christiansen D, Mouhtouris E, Milland J, et al. Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161). Xenotransplantation 2006;13:440-446 (Pubitemid 44265713)
67. Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 2007;446:1023-1029 (Pubitemid 46676064)
68. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002;9:376-381 (Pubitemid 36358933)
69. Miwa Y, Kobayashi T, Nagasaka T, et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004;11:247-253
70. Padler-Karavani V, Yu H, Cao H, et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 2008;18:818-830
71. Higashi H, Naiki M, Matuo S, Okouchi K. Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. Biochem Biophys Res Commun 1977;79:388-395
72. Chou HH, Takematsu H, Diaz S, et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 1998;95:11751-11756 • The genetic basis for the lack of a synthetic pathway for generation of Neu5Gc from Neu5Ac in humans was determined, which is one of only a few major genetic differences between humans and chimpanzees. (Pubitemid 28460486)
73. Byres E, Paton AW, Paton JC, et al. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 2008;456:648-652